Table I.

Assessment of left ventricular size and function

Parameter MCM;RbL/L;p130+/+ MCM+;RbL/L;p130+/+ MCM;RbL/L;p130−/− MCM+;RbL/L;p130−/− 
TAM 
HR (bpm) 477 ± 6 473 ± 14 475 ± 16 480 ± 12 
EF (%) 56.13 ± 2.02 50.40 ± 2.65 56.39 ± 3.32 33.52 ± 2.81a 
FS (%) 28.88 ± 1.29 25.32 ± 1.59 29.13 ± 2.31 15.97 ± 1.50a 
LVID;d (mm) 3.87 ± 0.07 3.98 ± 0.15 3.76 ± 0.02 4.78 ± 0.28a 
LVID;s (mm) 2.74 ± 0.08 2.98 ± 0.16 2.67 ± 0.08 4.02 ± 0.28a 
LVPW;d (mm) 0.63 ± 0.03 0.65 ± 0.14 0.67 ± 0.02 0.78 ± 0.03a 
LVPW;s (mm) 0.89 ± 0.02 0.89 ± 0.03 0.89 ± 0.02 0.78 ± 0.03a 
Parameter MCM;RbL/L;p130+/+ MCM+;RbL/L;p130+/+ MCM;RbL/L;p130−/− MCM+;RbL/L;p130−/− 
TAM 
HR (bpm) 477 ± 6 473 ± 14 475 ± 16 480 ± 12 
EF (%) 56.13 ± 2.02 50.40 ± 2.65 56.39 ± 3.32 33.52 ± 2.81a 
FS (%) 28.88 ± 1.29 25.32 ± 1.59 29.13 ± 2.31 15.97 ± 1.50a 
LVID;d (mm) 3.87 ± 0.07 3.98 ± 0.15 3.76 ± 0.02 4.78 ± 0.28a 
LVID;s (mm) 2.74 ± 0.08 2.98 ± 0.16 2.67 ± 0.08 4.02 ± 0.28a 
LVPW;d (mm) 0.63 ± 0.03 0.65 ± 0.14 0.67 ± 0.02 0.78 ± 0.03a 
LVPW;s (mm) 0.89 ± 0.02 0.89 ± 0.03 0.89 ± 0.02 0.78 ± 0.03a 

2D echocardiographic analysis of left ventricle function in mice with the indicated genotypes 4 wk after TAM treatment. n = 5 mice per group. Results are presented as the mean ± SEM. HR, heart rate; EF, ejection fraction; FS, fractional shortening; LVID;d/s, left ventricular internal dimension in diastole/systole; LVPW;d/s, left ventricular posterior wall thickness in diastole/systole.

a

P < 0.05 by analysis of variance for MCM;RbL/L;p130+/+, MCM+;RbL/L;p130+/+, and MCM;RbL/L;p130−/− versus MCM+;RbL/L;p130−/− littermates.

or Create an Account

Close Modal
Close Modal